Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential
- PMID: 33125926
- PMCID: PMC7834563
- DOI: 10.1016/S0140-6736(20)32259-5
Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential
References
-
- Ellenberg SS, Fleming TR, DeMets DL. second edn. John Wiley and Sons; New York: 2019. Data monitoring committees in clinical trials: a practical perspective.
-
- Business Wire Pfizer and BioNTech propose expansion of pivotal COVID-19 vaccine trial. Business Wire. Sept 12, 2020 https://www.businesswire.com/news/home/20200912005013/en/
-
- Loftus P. Moderna CEO eyes December for COVID vaccine. MarketWatch. Oct 19, 2020 https://www.marketwatch.com/story/moderna-ceo-eyes-december-for-covid-va...
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical